Literature DB >> 2897424

Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices.

Y Goshima1, T Kubo, Y Misu.   

Abstract

Biphasic electrical field stimulation (0.5-5 Hz, 2 ms, 25 V, 3 min) and high K+ (10-30 mM, 5 min) released endogenous 3,4-dihydroxyphenylalanine (DOPA) from superfused rat striatal slices. Characteristics of the DOPA release were compared with those of 3,4-dihydroxyphenylethylamine (dopamine, DA). Electrical stimulation at 2 Hz evoked DOPA and DA over similar time courses. alpha-Methyl-p-tyrosine (0.2 mM) markedly reduced release of DOPA but not of DA. Maximal release (0.3 pmol) of DOPA was obtained at 2 Hz and at 15 mM K+. The impulse-evoked release of DOPA and DA was completely tetrodotoxin (0.3 microM) sensitive and Ca2+ dependent and the 15 mM K+-evoked release was also Ca2+ dependent. On L-[3,5-3H]tyrosine (1 microM) superfusion, high K+ (15 and 60 mM) released DOPA and DA together with concentration-dependent decreases in tyrosine 3-monooxygenase (EC 1.14.16.2) activity as indicated by [3H]H2O formation, followed by concentration-dependent increases after DOPA and DA release ended. These findings suggest that striatal DOPA is released by a Ca2+-dependent excitation-secretion coupling process similar to that involved in transmitter release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897424     DOI: 10.1111/j.1471-4159.1988.tb02470.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii.

Authors:  Y Hiroshima; H Miyamoto; F Nakamura; D Masukawa; T Yamamoto; H Muraoka; M Kamiya; N Yamashita; T Suzuki; S Matsuzaki; I Endo; Y Goshima
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Synthesis and release of dopamine in rat striatal slices: requirement for exogenous tyrosine in the medium.

Authors:  R L Büyükuysal; E Moğol
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

3.  L-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptor.

Authors:  Daiki Masukawa; Motokazu Koga; Anna Sezaki; Yuka Nakao; Yuji Kamikubo; Tatsuo Hashimoto; Yuki Okuyama-Oki; Aderemi Caleb Aladeokin; Fumio Nakamura; Utako Yokoyama; Hiromichi Wakui; Hiroshi Ichinose; Takashi Sakurai; Satoshi Umemura; Koichi Tamura; Yoshihiro Ishikawa; Yoshio Goshima
Journal:  JCI Insight       Date:  2017-09-21

4.  Non-dopaminergic neurons expressing dopamine synthesis enzymes: differentiation and functional significance.

Authors:  M V Ugryumov; V I Mel'nikova; P V Ershov; I S Balan; A Kalas
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

5.  Effects of 3-O-methyl on L-dopa-facilitated synthesis and efflux of dopamine from rat striatal slices.

Authors:  W Y Chang; R A Webster
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells.

Authors:  A I Geller; M J During; Y J Oh; A Freese; K O'Malley
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

Review 7.  l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease.

Authors:  Yoshio Goshima; Daiki Masukawa; Yuka Kasahara; Tatsuo Hashimoto; Aderemi Caleb Aladeokin
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

Review 8.  The Many Faces of G Protein-Coupled Receptor 143, an Atypical Intracellular Receptor.

Authors:  Beatriz Bueschbell; Prashiela Manga; Anke C Schiedel
Journal:  Front Mol Biosci       Date:  2022-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.